Jeffrey W. Runge, Director at PHARMATHENE, INC (PIP), bought 17,850 shares at $2.69 ($48K) on 2011-06-17, disclosed to the SEC on 2011-06-20.
Open-market purchase of $48k PIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |